Australia markets closed

Nascent Biotech, Inc. (NBIO)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.0417+0.0017 (+4.37%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
-1,925
-2,088
-2,801
-470.39
-958.767
-
Stock-based compensation
815.842
882.091
756.32
116.085
785.852
-
Change in working capital
-71.887
163.784
-317.335
911.176
-102.518
-
Accounts receivable
-
0
0
750
-750
-
Accounts payable
-
-
-245.519
167.06
230.401
327.028
Other working capital
-1,348
-1,186
-1,787
413.479
-986.784
-
Other non-cash items
-
327.909
1,630
325.431
86.662
-
Net cash provided by operating activities
-1,348
-1,186
-1,787
413.479
-986.784
-
Cash flows from financing activities
Debt repayment
-
-400
-275
-520
0
-
Common stock issued
-
1,561
0
-
-
115
Other financing activities
-
-
-
-0.5
-
-
Net cash used provided by (used for) financing activities
-
1,386
1,865
-320
985
-
Net change in cash
37.911
199.934
77.772
92.979
-1.783
-
Cash at beginning of period
9.48
172.186
94.414
1.435
3.218
-
Cash at end of period
47.391
372.12
172.186
94.414
1.435
-
Free cash flow
Operating cash flow
-1,348
-1,186
-1,787
413.479
-986.784
-
Free cash flow
-1,348
-1,186
-1,787
413.479
-986.784
-